Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
19.56
+0.81 (4.32%)
Apr 8, 2026, 1:23 PM EDT - Market open
Caris Life Sciences Revenue
In the year 2025, Caris Life Sciences had annual revenue of $812.03M with 96.97% growth. Caris Life Sciences had revenue of $292.89M in the quarter ending December 31, 2025, with 125.44% growth.
Revenue (ttm)
$812.03M
Revenue Growth
+96.97%
P/S Ratio
6.90
Revenue / Employee
$439,888
Employees
1,846
Market Cap
5.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 812.03M | 399.77M | 96.97% |
| Dec 31, 2024 | 412.26M | 106.13M | 34.67% |
| Dec 31, 2023 | 306.13M | 47.64M | 18.43% |
| Dec 31, 2022 | 258.49M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAI News
- 11 months ago - Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering - PRNewswire
- 11 months ago - Caris Life Sciences discloses rise in revenue in US IPO filing - Reuters
- 11 months ago - Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO - Renaissance Capital
- 11 months ago - Caris Life Sciences IPO Registration Document (S-1) - SEC